Biogen has announced a definitive agreement to acquire Apellis Pharmaceuticals for approximately $5.6 billion, a move that would expand its presence in complement-mediated diseases, including ...
Researchers are combining cohort studies and clinical trials to investigate how diet shapes the gut microbiome and impacts ...
A 2026 informational release covering VigorX Pro's prostate health and male vitality claims, the VitalPro ManForceX ...
A 2026 informational consumer overview of VitalRIZE's male enhancement and virility support positioning, ingredient research ...